Online:
Visits:
Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Global Companian Diagnostic Technologies Market (2017-2022) – Grow Pricing, Features, Reviews & Comparison of Alternatives

Thursday, March 23, 2017 5:54
% of readers think this story is Fact. Add your two cents.

(Before It's News)

New report on Companian Diagnostic Technologies is an in-vitro diagnostic process that provides information about therapeutic response of patient for a specific treatment. This tool improves the therapeutic efficiency and decreases healthcare cost. According to Pricewaterhouse Cooper (PwC) report, the number of pharmaceutical and diagnostic companies has increased from 19 in 2009 to 44 in 2010. Companion diagnostic is a segment of personalized medicine that includes drug-testing, therapies, clinical trials and research. Increase in demand for targeted therapies is attracting pharmaceutical companies to develop low cost and highly efficient drugs. Commercialization of Pfizer’s targeted lung cancer therapeutics and Roche’s personalized therapies indicated the increased value for companion diagnostic market. Companion diagnostic market growth is hindered because of latency in approval of technologies. Companies are taking longer time for approval of drugs and therapies. For Example, Abbott, Pfizer, Bayer, Life Technologies and GSK are facing challenges to receive approval for commercialization from the FDA.

Get Free Sample Report Of Companian Diagnostic Technologies Market @ http://www.marketresearchstore.com/report/world-companian-diagnostic-technologies-market-opportunities-and-68289#RequestSample

The demand for increased awareness in personalized medicines and cost effective diagnosis is changing the landscape of pharmaceutical companies. Companies engaged in diagnostic research are facing challenges in terms of adoption of novel therapies in healthcare market, and competition for gaining competitive advantages to position their products. This report focuses on recent development happened in companion diagnostic market and its comparative analysis, thereby providing intelligence to companies involved in personalized medicines.

The key players included are Assurerx Health, Asuragen Inc., Beckman Coulter Inc., Bg Medicine Inc., Biocrates Life Sciences Ag, Cardiodx, Celera, Dako (Agilent Technologies), Diagnocure Inc., Epigenomics Ag, Foundation Medicine Inc., Genelex Corp., Genmark Diagnostics.

Do Inquiry To Buy Report Of Companian Diagnostic Technologies Market @ http://www.marketresearchstore.com/report/world-companian-diagnostic-technologies-market-opportunities-and-68289#InquiryForBuying

THERAPEUTICS

  • Oncology diseases
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Others

BY GEOGRAPHY

  • North America
  • Europe
  • Asia-Pacific
  • ROW

KEY AUDIENCES

  • Pharmaceutical companies
  • Government regulatory authorities
  • Research companies
  • Academic institutes
  • Have questions ?

Contact Us:

Joel John
3422 SW 15 Street, Suit #8138,
Deerfield Beach, Florida 33442, USA
USA Tel: +1-386-310-3803
GMT Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Email: [email protected] 
Web: http://www.marketresearchstore.com/

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.